LEP and breast carcinoma: Biological markers of insulin resistance such as the insulin level, the insulin/glucose ratio, HOMA (homeostasis model assessment), adiponectin, leptin/adiponectin, and decreased SHBG (sex hormone binding globulin) have been associated with an increased risk of breast cancer essentially in postmenopausal women [69].